Effects of Protein Hydrolysate Supplement on Systemic Muscle Function Markers Following Resistance Type Exercise in Male Subjects

NCT05367648 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2022-05-10

No results posted yet for this study

Summary

The effect of exercise on serum concentrations of creatine kinase (CK) and subsequent use of protein hydrolysate supplementation, Elio, to influence the expression of CK following resistance type exercise in male subjects. A two subject trial of Elio administered 3 grams per day in assessing its effects on post-exercise increases in markers associated with muscle injury and exertion

Conditions

  • Muscle Injury

Interventions

DIETARY_SUPPLEMENT

Elio

Elio™ supplementation, a protein hydrolysate derived from fava bean protein extract

OTHER

Placebo

Placebo comparator

Sponsors & Collaborators

  • Nuritas Ltd

    lead INDUSTRY

Principal Investigators

  • Brian Keogh · Nuritas Ltd

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-24
Primary Completion
2020-10-09
Completion
2020-11-24

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05367648 on ClinicalTrials.gov